Agenda

23/11/2022

Therapy-induced senescence enhances the efficacy of HER2- directed antibody drug conjugates / A B-catenin-dependent RNA biogenesis program promotes TALL therapy resistance

Sala Marie Curie a les 14:00h

Us convidem al pròxim IMIM Seminar organitzat pel programa de càncer que tindrà lloc el dimecres 23/11/2022 a les 14:00h. El seminari constarà de dues xerrades, una a càrrec de Santiago Duro, investigador predoctoral del grup de recerca en Redirecció immune (IMIM) amb el títol "Therapy-induced senescence enhances the efficacy of HER2-directed antibody drug conjugates" i l'altra a càrrec de Violeta García, PhD, investigadora postdoctoral del grup de recerca en Cèl·lules mare i càncer (IMIM) amb el títol "A β-catenin-dependent RNA biogenesis program promotes TALL therapy resistance".

________________________________________________________________

We invite you to the next IMIM Seminar organized by the cancer program that will take place on Wednesday 23 November 2022 at 14:00 h. The seminar will consist of two talks, one by Santiago Duro, predoctoral researcher. Immune redirection research group (IMIM), entitled "Therapy-induced senescence enhances the efficacy of HER2-directed antibody drug conjugates" and the other by Violeta García, PhD, postdoctoral researcher. Stem cells and cancer research group (IMIM), which will be entitled: "A β-catenin-dependent RNA biogenesis program promotes TALL therapy resistance".

Poster

Tots els actes